Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.
ACS medicinal chemistry letters June 12, 2025 DOI: 10.1021/acsmedchemlett.5c00309
Summary
Imagine new treatments for brain conditions. Researchers have developed novel indole derivatives, exploring their potential as serotonergic psychedelic agents. These unique compounds show promise for treating psychosis, mental illness, and various CNS disorders. This work introduces a new class of powerful therapeutic agents, offering a hopeful path forward for complex neurological and psychiatric challenges.
Abstract
Provided herein are novel indole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for preparing such compounds.